109 related articles for article (PubMed ID: 3045321)
21. Benzopyranones and benzothiopyranones: a class of tyrosine protein kinase inhibitors with selectivity for the v-abl kinase.
Geissler JF; Roesel JL; Meyer T; Trinks UP; Traxler P; Lydon NB
Cancer Res; 1992 Aug; 52(16):4492-8. PubMed ID: 1643641
[TBL] [Abstract][Full Text] [Related]
22. Expression of an Abelson murine leukemia virus-encoded protein in Escherichia coli causes extensive phosphorylation of tyrosine residues.
Wang JY; Queen C; Baltimore D
J Biol Chem; 1982 Nov; 257(22):13181-4. PubMed ID: 6292177
[TBL] [Abstract][Full Text] [Related]
23. Viral oncogene expression during differentiation of Abelson virus-infected murine promonocytic leukemia cells.
Hines DL
Cancer Res; 1988 Apr; 48(7):1702-7. PubMed ID: 2832050
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
25. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts.
Saggioro D; Ferracini R; Di Renzo MF; Naldini L; Chieco-Bianchi L; Comoglio PM
Int J Cancer; 1986 Apr; 37(4):623-8. PubMed ID: 2420727
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to the ATP-binding site of the human epidermal growth factor (EGF) receptor as specific inhibitors of EGF-stimulated protein-tyrosine kinase activity.
Gullick WJ; Downward J; Foulkes JG; Waterfield MD
Eur J Biochem; 1986 Jul; 158(2):245-53. PubMed ID: 3015611
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of the major tyrosine protein kinase from the human promyelocytic cell line, HL60.
Ernould AP; Ferry G; Barret JM; Genton A; Boutin JA
Eur J Biochem; 1993 Jun; 214(2):503-14. PubMed ID: 8513800
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
29. Abelson-transformed fibroblasts contain nuclear phosphotyrosyl-proteins which preferentially bind to murine DNA.
Bell JC; Mahadevan LC; Colledge WH; Frackelton AR; Sargent MG; Foulkes JG
Nature; 1987 Feb 5-11; 325(6104):552-4. PubMed ID: 2433597
[TBL] [Abstract][Full Text] [Related]
30. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
Traxler PM; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Med Chem; 1996 Jun; 39(12):2285-92. PubMed ID: 8691423
[TBL] [Abstract][Full Text] [Related]
31. Specificity of the MAP kinase ERK2 for phosphorylation of tyrosine hydroxylase.
Royo M; Daubner SC; Fitzpatrick PF
Arch Biochem Biophys; 2004 Mar; 423(2):247-52. PubMed ID: 15001389
[TBL] [Abstract][Full Text] [Related]
32. Selective inhibition of tyrosine protein kinase by a synthetic multisubstrate analog.
Baginski I; Commerçon A; Tocqué B; Colson G; Zerial A
Biochem Biophys Res Commun; 1989 Dec; 165(3):1324-30. PubMed ID: 2558655
[TBL] [Abstract][Full Text] [Related]
33. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Itk tyrosine kinase: contribution of noncatalytic domains to enzymatic activity.
Hawkins J; Marcy A
Protein Expr Purif; 2001 Jul; 22(2):211-9. PubMed ID: 11437596
[TBL] [Abstract][Full Text] [Related]
35. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
36. In vivo tyrosine phosphorylations of the Abelson virus transforming protein are absent in its normal cellular homolog.
Ponticelli AS; Whitlock CA; Rosenberg N; Witte ON
Cell; 1982 Jul; 29(3):953-60. PubMed ID: 6185233
[TBL] [Abstract][Full Text] [Related]
37. Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.
Wang JY
Oncogene Res; 1988; 3(3):293-8. PubMed ID: 3144698
[TBL] [Abstract][Full Text] [Related]
38. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
[TBL] [Abstract][Full Text] [Related]
39. Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis.
Engelman A; Rosenberg N
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8021-5. PubMed ID: 2825174
[TBL] [Abstract][Full Text] [Related]
40. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
